Registration is now open for the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference focusing on neuromuscular diseases, including Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), myasthenia gravis, and Pompe disease, among others.

The conference will “showcase cutting-edge research advancements and clinical achievements in neuromuscular disease,” according to an MDA press release.

It will be held from March 19 to 22, 2023, in Dallas, Texas, and virtually.

Continue Reading

Read more about the treatment of DMD

There will be scientific sessions on topics such as advances in different types of neuromuscular disease, including clinical trial updates, ultrarare ones, mechanisms in repeat-mediated diseases, practical considerations in delivering gene therapy, support for diverse clinical trial participation and clinical management, technological advances for therapy development, and big data including digital and computational tools.

“MDA’s 2023 Conference brings together global leaders in our field for exciting presentations and announcements, exploring all aspects of preclinical, translational, and clinical research and care across neuromuscular disease to support the development of breakthrough treatments and stronger futures for our community,” said Donald S. Wood, PhD, the president and chief executive officer of MDA, in a press release.

“This year’s conference will take a particular look at emerging technologies in genetic medicine,” Sharon Hesterlee, PhD, the chief research officer of MDA, added. “The conference will feature leading experts pioneering these new techniques.”

The conference will be preceded by the annual gathering of the Neuromuscular Advocacy Collaborative, which brings together leaders from different advocacy organizations. The aim is to develop a shared public policy agenda to improve the lives of all people living with a neuromuscular disease.

Members of the neuromuscular disease community who are registered with the MDA can attend the virtual conference free of charge. Alternatively, they can register to attend in person at the patient/caregiver rate. 


Registration now open for 2023 MDA Clinical & Scientific Conference, to showcase cutting edge research advancements and clinical achievements in neuromuscular disease. News release. Muscular Dystrophy Association; September 12, 2022.